Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1687 of 6351
-
Could a vaccine stop the virus behind mono, cancer, and MS?
Vaccine Recruiting nowEpstein Barr virus (EBV) is a virus which can cause infectious mononucleosis and is associated with certain kinds of cancer and multiple sclerosis. Researchers are looking for new ways to prevent disease related to EBV and have developed a new study vaccine (V350A and V350B). The…
Phase 1 • Sponsor: Merck Sharp & Dohme LLC • Aim: Vaccine
Last updated Aug 27, 2026 00:00 UTC
-
New drug cocktail aims to tame multiple myeloma
Disease control Recruiting nowThe primary purpose of this study for Part 1 (Dose Escalation) is to identify the safe effective dose (recommended Phase 2 doses \[RP2Ds\]) and schedule for JNJ-79635322 treatment regimen in combination with daratumumab with or without lenalidomide or with pomalidomide; and for P…
Phase 1 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
Can Eye-Tracking and music make talk therapy work better for anxious kids?
Symptom relief Recruiting nowBackground: Anxiety disorders are becoming more common among children and teenagers. Anxiety can lead to long-term physical and mental problems, such as depression. Treatments for anxiety disorders include medications as well as cognitive behavioral therapy (CBT); CBT is a form …
Phase 2 • Sponsor: National Institute of Mental Health (NIMH) • Aim: Symptom relief
Last updated Aug 15, 2026 00:00 UTC
-
New drug combo aims to tame chronic hepatitis b
Disease control OngoingThis study uses random, double -blindness, placebo control, and phase multi -center test design. All subjects who meet the standards receive TQ-A3334 per tablet/placebo nucleoside (acid) analog. A total of 116 subjects are needed.
Phase 2 • Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
New PET scan technique could sharpen cancer detection in the gut
Diagnosis Recruiting nowThe aim of this study is to establish and optimize the target-specific PET/CT imaging method, and its physiological and pathological distribution characteristics, on the basis of which the diagnostic efficacy of the above imaging agents in digestive system malignant tumors will b…
Sponsor: RenJi Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 08:07 UTC
-
New hope for myeloma patients with kidney failure: safer CAR t therapy on the horizon
Disease control Recruiting nowTreatment for relapsed/refractory multiple myeloma continues to evolve with the approval of highly effective anti-BCMA CAR T therapies in recent years. However, despite the high prevalence of renal insufficiency in this population, pivotal clinical trials have excluded patients w…
Phase 1 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
New 5-Minute brain scanner could speed up ER triage
Diagnosis Recruiting nowThe goal of this clinical study is to evaluate how accurately and safely the TES HT100 device can identify intracranial abnormalities in adult emergency department patients with mild head trauma or neurological symptoms that are not related to trauma and are not immediately life-…
Sponsor: B&B srl • Aim: Diagnosis
Last updated Jun 27, 2026 12:00 UTC
-
New hope for teens with chronic Graft-Versus-Host disease: belumosudil under study
Disease control CompletedThis is a single group, Phase 4, single-arm post-marketing study for treatment. The purpose of this study is to verify the pharmacokinetics, efficacy, and safety of belumosudil mesylate tablets in Chinese adolescent participants (aged from 12 to less than 18) with cGVHD who have…
Phase 4 • Sponsor: Sanofi • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
Could a Three-Pronged attack keep High-Risk leukemia at bay?
Disease control Stopped earlyThe purpose of this study is to see the effects of an investigational combination treatment of venetoclax, azacitidine, and donor lymphocyte infusion (DLI) in patients with high-risk AML receiving allogeneic hematopoietic cell transplantation, and to assess if the combination tre…
Phase 1 • Sponsor: Antonio M Jimenez Jimenez • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Can a heart pump spark its own recovery? a new study investigates
Knowledge-focused Recruiting nowThis observational study is being done to learn more about heart attack recovery in patients supported with the Impella 5.5 left ventricular assist device (LVAD) as part of their standard of care. There are three stages in this study: screening, treatment and post treatment. Ther…
Sponsor: Columbia University • Aim: Knowledge-focused
Last updated Aug 21, 2026 00:00 UTC
-
AI-Powered ECG could spare thousands from invasive heart tests
Diagnosis Recruiting nowAngina pectoris is diagnosed in \>180.000 people in the Netherlands each year. Diagnosis in angina pectoris focuses on epicardial coronary stenosis, the identification of which may lead to guideline-directed medical therapy or revascularization. However, no such stenosis is ident…
Sponsor: UMC Utrecht • Aim: Diagnosis
Last updated Jun 27, 2026 08:10 UTC
-
New study tests rinvoq for psoriatic arthritis spine pain
Disease control Recruiting nowA Randomized, Placebo-controlled, Multicenter, Study to Evaluate the Impact of Upadacitinib on Spondyloarthritis Outcomes in Patients with Active Psoriatic Arthritis (UP-SPOUT)
Phase 4 • Sponsor: CARE ARTHRITIS LTD. • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
New biologic injection aims to ease stuffy nose and sinus pain in nasal polyp patients
Symptom relief OngoingThe main objective of this study is to evaluate treatment outcomes of tezepelumab among participants with physician-determined surgery-eligible CRSwNP, with or without asthma. Study details include: 1. The study duration will be up to 40 weeks. 2. The treatment duration will be…
Phase 3 • Sponsor: AstraZeneca • Aim: Symptom relief
Last updated Sep 10, 2026 02:00 UTC
-
Newborn DNA screening could slash time to rare disease diagnosis
Knowledge-focused Recruiting nowThe main objective of the genetic newborn screening part of the Screen4Care-project is to shorten the path to rare disease diagnosis and to facilitate early intervention. Therefore, genetic newborn screening for currently treatable rare diseases (TREAT-panel approach) will be off…
Sponsor: University Hospital Freiburg • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:28 UTC
-
New artery-delivered combo shows promise against bone cancer
Disease control CompletedThe goal of this clinical trial is to learn the efficacy and safety of intra-arterial cisplatin plus anti-angiogenesis inhibitor rh-endostatin (Endostar) combined with systematic chemotherapy in osteosarcoma. The main questions it aims to answer are: * Is it safe when rh-endosta…
Phase 1/2 • Sponsor: Shanghai 6th People's Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
New inhaled compound aims to ease COPD breathing woes
Disease control CompletedThis is a randomized, double-blind, placebo-controlled, dose escalation, multicenter study design. The purpose is to evaluate the safety, tolerability, pharmacokinetics, and pharmacokinetic characteristics of TQC3721 inhalation powder in Chronic Obstructive Pulmonary Disease(COPD…
Phase 1 • Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
CF breakthrough: kids may ditch daily enzyme pills after modulator treatment
Disease control CompletedThe goal of this clinical trial is to evaluate the safety of stopping pancreatic enzyme replacement therapy (PERT) in children with cystic fibrosis (CF) receiving CFTR modulator therapy (CFTRm) who have regained pancreatic sufficiency. The main questions it aims to answer are: 1…
Phase 4 • Sponsor: Indiana University • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
A Six-Session CBT program may curb internet addiction in college students
Disease control CompletedProblematic internet use, using the internet in ways that interfere with daily life, is a growing concern among university students in Nepal, where studies report prevalence rates between 21.5% and 35.4%. Despite this, structured, evidence-based intervention trials in Nepalese ac…
Sponsor: Tribhuvan University, Nepal • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
New hope for rare epilepsy: drug ION283 enters human trials
Disease control Recruiting nowThis study will test the safety and efficacy of multiple doses of ION283 administered as intrathecal (IT) injections by lumbar puncture (LP). All subjects will receive ION283. The dose level of 15 mg will be studied in all subjects.
Phase 1/2 • Sponsor: Berge Minassian • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
AI could speed up radiation planning by automatically mapping healthy tissues
Knowledge-focused Recruiting nowThis study measures the utility of a novel artificial intelligence (AI) algorithm for performing auto-segmentation of computed tomography (CT) scans for radiation therapy planning.
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Jul 10, 2026 00:00 UTC